The systemic response to surgery triggers the outgrowth of distant immune -
controlled tumors in mouse models of dormancy
Not exact matches
While study results indicated that combining capsaicin with the chemicals «might promote cancer cell survival,» the report clearly stated that the
control group of
mice treated only with capsaicin ``... did not induce any skin
tumors...»
In addition, the study repeatedly cited other research studies in which the anti-cancer properties of capsaicin were solidly demonstrate
In addition, the study repeatedly cited other research studies
in which the anti-cancer properties of capsaicin were solidly demonstrate
in which the anti-cancer properties of capsaicin were solidly demonstrated.
In the
mice that received GD2 CAR - T cells, the DIPG
tumors were undetectable after 14 days, while
mice receiving the
control treatment had no
tumor regression.
When injected with cancer cells, animals housed there developed
tumors 80 % smaller than those
in control mice, or no
tumors at all.
Compared to a
control (left), epalrestat treatment (right) reduces the number of metastatic
tumors (arrowheads)
in the lungs of
mice injected with human basal - like breast cancer cells.
In a
mouse model of triple - negative breast cancer,
mice injected with cancer cells that over-express ZMYND11 had
tumor volumes of less than 50 cubic millimeters while
control mice and those injected with cells expressing ZMYND11 deficient for binding to the methyl group had
tumor volumes ranging from 150 to 400 cubic millimeters at eight weeks.
For the animal study, the researchers separated 52
mice with colon cancer
tumors into three groups, including a
control group and groups that were fed either the grape compounds or sulindac, an anti-inflammatory drug, which was chosen because a previous study showed it significantly reduced the number of
tumors in humans.
In animal models, the modified T cells greatly reduced the
tumor burden and prolonged overall survival: All
mice that received the modified T cells were alive 44 days after treatment versus 29 percent and 17 percent of the study's two
control groups.
«For example,
mouse mammary
tumors shared a signaling pathway that is found
in human lung cancer and
controls how cells reproduce and move from one location to another.»
In the experiment, that conversion wasn't tightly
controlled; somewhat creepily, the
mice developed
tumors that resembled embryos.
When the researchers administered MCB - 613 to 13
mice with breast cancer, the drug candidate almost completely eliminated
tumor growth without causing toxicity, whereas
tumors continued to grow by about 3-fold over 7 weeks
in the
control group of 14
mice.
The
tumors grew rapidly
in the
control experiments (the median time for
tumor - free survival was one week) and any differences
in tumor - free survival for the
controls and the
mice injected with cells expressing mutated PREX2 were not statistically significant (Horrigan et al., 2017).
In the replicating lab, however, tumors grew extremely slowly in both treated mice and in controls — and in a few cases spontaneously regresse
In the replicating lab, however,
tumors grew extremely slowly
in both treated mice and in controls — and in a few cases spontaneously regresse
in both treated
mice and
in controls — and in a few cases spontaneously regresse
in controls — and
in a few cases spontaneously regresse
in a few cases spontaneously regressed.
Specifically, TheraT ® has proven to be safe
in animals as well as capable of eliciting uniquely potent antigen - specific CD8 + cytotoxic T cell responses and strong
tumor control in mice.
The decreased
tumor size and enhanced
tumor rejection
in DGKζ - deficient
mice indirectly suggests that enhanced Erk signaling may be superior to enhanced NF - κΒ activation
in facilitating T cell activity against
tumor, especially because DKO
mice did not exhibit improved
tumor control relative to DGKζ − / −
mice.
In the study, Kwong's team successfully put their remote - control method through initial tests in mice with implanted tumors (so - called tumor phantoms, specially designed for certain experiments
In the study, Kwong's team successfully put their remote -
control method through initial tests
in mice with implanted tumors (so - called tumor phantoms, specially designed for certain experiments
in mice with implanted
tumors (so - called
tumor phantoms, specially designed for certain experiments).
Collectively, these data indicate that DGKζ − / −
mice exert improved
control of orthotopically implanted KPC1242
tumors, compared with WT
mice,
in a manner that may result from changes
in the number of intratumoral activated CD8 + T cells
in DGKζ − / −
mice.
Similarly, Cbl - b − / −
mice and T cells lacking Cbl - b demonstrate improved
control of s.c. - implanted
tumors (23) and disseminated leukemia (32), along with decreased spontaneous
tumor formation
in ATM − / −
mice (23) and UV B - treated
mice (24).
Conditional expression of fascin led to decrease
in mice survival and increase
in tumor burden compared to
control animals.
In the animal study, researchers divided a group of 52
mice with colon cancer
tumors into three groups: a
control group, a group fed the grape compounds and a group given sulindac, an anti-inflammatory drug that an earlier study showed decreased the incidence of
tumors.
Sulforaphane, a putative anticarcinogen
in broccoli, was provided orally to
mice bearing androgen - insensitive human PC - 3 xenografts, and resulted
in tumor volumes of 207 ± 35 and 90 ± 22 mm3 for the
control and sulforaphane groups, respectively (22).
Additionally,
tumor weights
in the sulforaphane - treated
mice were one - fourth those of the
control tumors (P < 0.05).